OR WAIT null SECS
May 15, 2018
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
May 14, 2018
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
May 10, 2018
The technology, known as Verifi, is available with the ChargePoint’s range of valves that ensure safe and contamination-free handling of API and other formulation ingredients.
May 09, 2018
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
May 08, 2018
The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar.
May 07, 2018
The data and analytics company reports on the anticipated uptake of Humira (adalimumab) biosimilars in the EU once they are launched in 2018.
Lonza announces addition of mid-scale biologics manufacturing capacity and cell-therapy suites at Portsmouth, NH site.
May 02, 2018
Choice of carrier can have a significant impact on the capsule filling process as well as the performance of the DPI formulation.
Public health authorities and the biomedical research community are seeking new strategies to address global health threats.
A skilled workforce is needed to deliver on technology’s promising medical advances.